Changes to NHS vaccine programmes ‘will ultimately save lives’
NHS England have announced a million more people are eligible for a shingles vaccine, while the HPV jab will be reduced to one dose.
At the beginning of this month the NHS updated two of its life-saving vaccination programmes, following the latest advice given by the Joint Committee on Vaccination and Immunisation (JCVI), which will make it easier for people to get protected – especially those more vulnerable.
The expanded shingles programme will include people who turned 65 and 70 from 1st September 2023, as well as those over the age of 50 with a weakened immune system. Patients will be invited to book an injection at their local GP surgery, with 900,000 expected to be newly-eligible.
According to recent research, it is estimated that around one in five people will develop shingles in their lifetime, which can cause individuals to go blind, experience nerve pain, hearing loss and in extreme cases death.
People can be infected with the disease at any age, but the severity of the illness can increase as people get older.
In addition to more people being able to receive the shingles vaccine, the NHS have also announced the HPV vaccine, which was launched in 2008, will now be reduce to one dose instead of two.
The jab, which helps to prevent a range of cancers, including cervical, cancers of the head, neck, mouth, throat, annus and genital areas, is offered to all children in year eight at school.
Dr Mary Ramsay, head of immunisation at the UKHSA, said: ‘Shingles is an extremely painful condition and complications can be long-lasting. Older people and those with weakened immune systems are particularly vulnerable so I’d encourage all those newly eligible from today to come forward.
‘With the HPV vaccine, a move to one dose for most of those eligible will make it quicker and easier to get protected. Latest evidence shows that one dose provides just as robust protection as two, so young people can be confident they are protected against the risks, including cancers, that the HPV virus poses.’
Steve Russell, national director of vaccinations and screening at NHS England, added: ‘Making these vital changes to two life-saving NHS vaccination programmes will help protect millions of people, prevent disease, and ultimately save lives.
‘These measures have the backing of the country’s leading medical experts who continually look for ways to update our programmes and ensure those who need it are offered the best protection against serious illnesses.
‘If you are eligible and have a chance to receive one of these vaccines, please do not ignore it – these vaccines continue to save lives so please take up the opportunity when you can.’
Image: CDC
Flu and Covid autumn vaccine programmes brought forward due to new variant